| Pharmaceutical Information |
| Drug Name |
Isoxsuprine hydrochloride |
| Drug ID |
BADD_D01215 |
| Description |
A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor. |
| Indications and Usage |
Not Available |
| Marketing Status |
approved; withdrawn |
| ATC Code |
C04AA01 |
| DrugBank ID |
DB08941
|
| KEGG ID |
D01748
|
| MeSH ID |
D007556
|
| PubChem ID |
11368
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
49706-0921; 38779-0234; 71052-226; 82053-001 |
| UNII |
V74TEQ36CO
|
| Synonyms |
Isoxsuprine | Duvadilan | Isoxsuprine Hydrochloride | Hydrochloride, Isoxsuprine |
|
| Chemical Information |
| Molecular Formula |
C18H24ClNO3 |
| CAS Registry Number |
579-56-6 |
| SMILES |
CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
